
Dicerna Pharmaceuticals (DRNA)
Order type
Buy in
Order amount
Est. shares
0 shares
Buy Dicerna Pharmaceuticals (DRNA) Stock
Start investing in Dicerna Pharmaceuticals (DRNA)
About Dicerna Pharmaceuticals (DRNA)
Market cap | $2.98B |
Today's volume | — |
Revenue (TTM) | — |
Avg. daily volume | 2.73M |
EBITDA (TTM) | — |
Open | — |
Price / earnings ratio | -23.44x |
Today's range | — |
Debt / equity | — |
52 week range | $19.06 - $40.14 |
5 year debt / equity | 9.72x |
Beta (LTM) | 0.98x |
Interest coverage | — |
Dividend & yield | $0.00 (0.00%) |
Current ratio | — |
Ex-dividend date | — |
Next earnings | Nov 9, 2021 |
Dividend payable date | — |
Dicerna Pharmaceuticals Stock News
View all



Frequently Asked Questions (FAQ)
How to buy DRNA stock on Public
- 1
Sign up for a brokerage account on Public
It’s easy to get started. You can sign up for an account directly on our website or by downloading the Public app for iOS or Android.
- 2
Add funds to your Public account
There are multiple ways to fund your Public account—from linking a bank account to making a deposit with a debit card or wire transfer.
- 3
Choose how much you'd like to invest in DRNA stock
Navigate to the Explore page. Then, type DRNA into the search bar. When you see DRNA stock appear in the results, tap it to open up the purchase screen.
- 4
Manage your investments in one place
You can find your newly purchased DRNA stock in your portfolio—alongside the rest of your stocks, ETFs, crypto, treasuries, and alternative assets.
Dicerna Pharmaceuticals Stock Earnings
The value each DRNA share was expected to gain vs. the value that each DRNA share actually gained.
Dicerna Pharmaceuticals (DRNA) reported Q3 2021 earnings per share (EPS) of -$0.22, beating estimates of -$0.46 by 52.17%. In the same quarter last year, Dicerna Pharmaceuticals's earnings per share (EPS) was -$0.29. Dicerna Pharmaceuticals is expected to release next earnings on 11/09/2021, with an earnings per share (EPS) estimate of $0.